Global One-step ELISA Market Growth (Status and Outlook) 2023-2029

Global One-step ELISA Market Growth (Status and Outlook) 2023-2029

ELISA is one of the gold standards for in-vitro diagnostic testing.

LPI (LP Information)' newest research report, the “One-step ELISA Industry Forecast” looks at past sales and reviews total world One-step ELISA sales in 2022, providing a comprehensive analysis by region and market sector of projected One-step ELISA sales for 2023 through 2029. With One-step ELISA sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world One-step ELISA industry.

This Insight Report provides a comprehensive analysis of the global One-step ELISA landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on One-step ELISA portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global One-step ELISA market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for One-step ELISA and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global One-step ELISA.

The global One-step ELISA market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for One-step ELISA is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for One-step ELISA is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for One-step ELISA is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key One-step ELISA players cover Abcam, BosterBio, DIALAB, AnaSpec, IDS, PerkinElmer and InBios International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of One-step ELISA market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
IgG
Albumin
TNF alpha
IL-6
Fibrinogen
Insulin
Lysozyme
Others

Segmentation by application
Pharmaceutical and Biotechnology Companies
Diagnostic Centers
Hospitals and Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abcam
BosterBio
DIALAB
AnaSpec
IDS
PerkinElmer
InBios International

Please note: The report will take approximately 2 business days to prepare and deliver.